Epidermal Growth Factor Receptor Inhibitor Skin Rash Prophylaxis in a Community Oncology Setting

Epidermal growth factor receptor inhibitors (EGFRIs) can potentially cause a debilitating rash despite use of reactive-based treatment. Prophylactic rash management is a controversial rash-mitigating approach. The impact of a prophylactic rash treatment protocol for EGFRIs at a community hospital wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Pepper, Micah S., May, Megan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505548/
https://www.ncbi.nlm.nih.gov/pubmed/31086685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505548/
https://www.ncbi.nlm.nih.gov/pubmed/31086685

Ejemplares similares